Why is Medicare proposing new cuts to 340B drug payments in 2024?

Medicare has proposed reducing payments to hospitals for drugs purchased under the federal 340B program, seeking to reset reimbursement levels that officials view as too high. The move revives earlier efforts to realign 340B economics after prior cuts were blocked, potentially pressuring safety‑net and rural hospitals dependent on those margins.